Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children
Open Access
- 10 September 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 5 (10) , ofy222
Abstract
In this multicenter study, we identified an increased risk of 30-day mortality among hospitalized children with carbapenem-resistant Enterobacteriaceae (CRE) isolated from clinical cultures compared with those with carbapenem-susceptible Enterobacteriaceae. We additionally report significant variation in antibiotic treatment for children with CRE infections with infrequent use of combination therapy.Keywords
Funding Information
- National Institute of Child Health and Human Development (T32HD060550)
- National Institute of Allergy and Infectious Diseases (K23-AI127935, K01-AI103028)
- Centers for Disease Control and Prevention (FOA#CK16-004)
This publication has 13 references indexed in Scilit:
- Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in ChildrenAntimicrobial Agents and Chemotherapy, 2017
- Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort studyThe Lancet Infectious Diseases, 2017
- Clinical and Bacterial Risk Factors for Mortality in Children With Carbapenem-resistant Enterobacteriaceae Bloodstream Infections in IndiaThe Pediatric Infectious Disease Journal, 2017
- Carbapenem-resistant Enterobacteriaceae Infections in ChildrenThe Pediatric Infectious Disease Journal, 2016
- Carbapenem-ResistantEnterobacteriaceaein Children, United States, 1999–2012Emerging Infectious Diseases, 2015
- Pediatric Carbapenem-resistant Enterobacteriaceae in Los Angeles, California, a High-prevalence Region in the United StatesThe Pediatric Infectious Disease Journal, 2015
- Carbapenemase-Producing Enterobacteriaceae (CPE) in the Pediatric Setting: Results from an 18-Month SurveyInfection Control & Hospital Epidemiology, 2014
- Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of CarbapenemsAntimicrobial Agents and Chemotherapy, 2014
- Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae BacteremiaInfection Control & Hospital Epidemiology, 2009
- Matched Cohort Methods for Injury ResearchEpidemiologic Reviews, 2003